AstraZeneca Boosts Cancer Therapies Push With $1 Billion EsoBiotec Buy
(Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said ...
M&A News: AstraZeneca Seals Belgian Firm EsoBiotec Deal to Boost Cell Therapy
Healthcare giant AstraZeneca (AZN) is set to buy Belgian firm EsoBiotec for up to $1 billion. The deal aims to speed up progress in cell ...
Reuters2d
AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
It bought China-based Gracell Biotechnologies for up to $1.2 billion in December 2023 and, in February 2024, said it would invest $300 million for the discovery and development of cell therapies.
AstraZeneca to buy EsoBiotec for up to $1 billion
(Reuters) -Drugmaker AstraZeneca has agreed to buy biotechnology company EsoBiotec for up to $1 billion, it said on Monday, ...
pharmaphorum3d
AZ makes another cell therapy play with $1.2bn Gracell buy
AstraZeneca has lined up a $1.2 billion takeover deal for Chinese biotech Gracell Biotechnologies, bolting a series of cell therapies for cancer and autoimmune diseases onto its pipeline.